Author

Bryan Jimenez-Araya

Centre National de la Recherche ScientifiqueORCID 0009-0006-1962-0666Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:E. coli· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdelhakim Ahmed‐BelkacemiD· 1 shared Alexandre BancetiD· 1 shared Angélique MularoniiD· 1 shared Anna G. BurrichteriD· 1 shared Bärbel StecheriD· 1 shared Benoît ChassaingiD· 1 shared D. Grenier· 1 shared Dennis Salomon Lopez MolinaiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Abdelhakim Ahmed‐BelkacemORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 5, 2026

Bivalent CK2 Inhibition as a Potent Strategy Against SARS-CoV-2 and Other Coronaviruses

Dennis Salomon Lopez Molina, Nazim Ahnou, Rozenn Brillet…·Abdelhakim Ahmed‐Belkacem

This study identifies CK2 as a critical host factor for SARS-CoV-2 replication and shows that the bivalent inhibitor AB668 effectively inhibits multiple coronaviruses.

DOI 10.64898/2026.10.05.756735

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintJan 8, 2026

Oral Fumarate-based drugs alter gut microbiota species via cysteine succination

Marie Anselmet, Anna G. Burrichter, Thibaut Douché…·Rodrigo Arias-Cartín

This study shows fumarate-based drugs modify gut bacteria via cysteine succination, affecting their functions and interactions in both isolated cultures and microbial communities.

DOI 10.64898/2026.01.08.698357

E. coliproteomics

𝕏 PostBluesky